After eight years with no new treatments for ovarian cancer, PARP inhibitors and anti-angiogenics are benefiting patients.
Jessica D’Amico
Advertisement
Articles by Jessica D’Amico
Advertisement
Latest Updated Articles
- Ending a Dry Spell of Years Without Treatment for Ovarian Cancer
Published: April 26th 2017 | Updated:
Advertisement
Advertisement
Trending on CURE
1
Areola Tattooing Helped Stephanie Wachtel Reclaim Confidence After Cancer
2
Kisqali Plus Aromatase Inhibitor Shows Long-Term Benefit in Early Breast Cancer
3
Tagrisso Plus Chemo Offers Survival benefit in EGFR+ NSCLC
4
Lymphoma Survivors Find Fatigue Relief From Multidisciplinary Intervention
5
